Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	12/21/2010 5:26:26 PM
	of 3158

MATK munched this morning. 6:27AM Martek Biosci to be acquired by Royal DSM for $31.50 per share in cash for total consideration of $1.087 bln (MATK) 23.36 : The tender process is expected to close in February 2011, and the transaction is expected to close in the first or second quarter of 2011. The agreed price represents a premium of 35% to Martek's closing share price of US$23.36 on December 20, 2010, and 39% to the volume weighted average closing price of Martek's common stock over the last 90 days. The acquisition is immediately EPS accretive for DSM by 15 to 20 euro cents per ordinary share on a full year basis.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next